ストックスクリーナーアプリを入手
0.6247
1.31%
-0.0083
アフターアワーズ：
.60
-0.0247
-3.95%
前日終値:
$0.633
開ける：
$0.63
24時間の取引高:
47,621
Relative Volume:
0.20
時価総額：
$5.09M
収益：
$11.67M
当期純損益:
$-2.79M
株価収益率:
-1.6513
EPS:
-0.3783
ネットキャッシュフロー:
$-2.55M
1週間 パフォーマンス:
-7.49%
1か月 パフォーマンス:
-45.68%
6か月 パフォーマンス:
-74.24%
1年 パフォーマンス:
-79.25%
1日の値動き範囲:
$0.61
$0.6609
1週間の範囲:
$0.5772
$0.7252
52週間の値動き範囲:
$0.5772
$3.0191
Nexgel Inc Stock (NXGL) Company Profile
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.6247 | 5.15M | 11.67M | -2.79M | -2.55M | -0.3783 |
ISRG
Intuitive Surgical Inc
|
464.45 | 163.73B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.34 | 44.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.51 | 36.73B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.00 | 36.12B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
222.85 | 32.70B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc (NXGL) 最新ニュース
Shootin' the Bull about "has to" - barchart.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Published on: 2026-04-01 05:28:13 - baoquankhu1.vn
NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative
NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - tradingview.com
Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - tradingview.com
NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan
NXGL PE Ratio & Valuation, Is NXGL Overvalued - intellectia.ai
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - marketscreener.com
NEXGEL Reschedules 2025 Financial Results Conference Call - GlobeNewswire
NEXGEL delays earnings call a week to add detail on Celularity deal - Stock Titan
Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN
Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn
Published on: 2026-03-28 04:45:25 - baoquankhu1.vn
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - tradingview.com
NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - ad-hoc-news.de
3 Stocks Under $50 That Concern Us - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
Oxford Industries Earnings: What To Look For From OXM - Barchart
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - defenseworld.net
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
Nexgel Inc (NXGL) 財務データ
収益
当期純利益
現金流量
EPS
1.45%
0.76%
大文字化:
|
ボリューム (24 時間):